Plasma expansion and renal perfusion in critical COVID‐19 with <scp>AKI</scp>: A prospective case control study
Plasma expansion with a standardized fluid bolus did not increase renal perfusion in critically ill patients with COVID-19, with or without AKI.
Authors
- Tomas Luther (ORCID: https://orcid.org/0000-0003-4449-3831)
- Eleanor Cox (ORCID: https://orcid.org/0000-0001-7899-0778)
- Fredrik Palm (ORCID: https://orcid.org/0000-0002-0127-3348)
- Susan Francis (ORCID: https://orcid.org/0000-0003-0903-7507)
- Ján Weis (ORCID: https://orcid.org/0000-0003-2448-9245)
- Michael Hultström (ORCID: https://orcid.org/0000-0003-4675-1099)
- Miklós Lipcsey (ORCID: https://orcid.org/0000-0002-1976-4129)
- Sara Bülow‐Anderberg (ORCID: https://orcid.org/0000-0002-8769-7036)
- Per Eckerbom
- Robert Frithiof (ORCID: https://orcid.org/0000-0003-2278-7951)
- Per Liss (ORCID: https://orcid.org/0000-0003-4379-0906)
Institutions
- Uppsala University (SE)
- Nottingham University Hospitals NHS Trust (GB)
- Uppsala University Hospital (SE)
- University of Nottingham (GB)
- Nottingham Biomedical Research Centre (GB)
Publication Details
- Journal
- Acta Anaesthesiologica Scandinavica
- Published
- 2025-02-23
- DOI
- https://doi.org/10.1111/aas.70004
- Citations
- 1
- Primary Topic
- Acute Kidney Injury Research
- Type
- article
- Field-Weighted Citation Impact
- 1.43
Funders
- Hjärt-Lungfonden
- Knut och Alice Wallenbergs Stiftelse
- Vetenskapsrådet
- Akademiska Sjukhuset
- Stiftelsen Familjen Ernfors Fond
- Svenska Läkaresällskapet
- Njurfonden
- Science for Life Laboratory
- Region Uppsala
- Medical Research Council